Assistant Professor of Biomedical Informatics
Harvard Medical School
Dr. Farhat is an Assistant Professor of of
Biomedical Informatics atHarvard Medical School and a a practicing physician at
the Massachusetts General Hospital Division of Pulmonary and Critical Care
Medicine.
Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. Farhat's work has focused on bacterial and viral pathoges and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.
Maha Farhat holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health.
Assistant Professor of Biomedical Informatics
Harvard Medical School
Dr. Farhat is an Assistant Professor of of
Biomedical Informatics atHarvard Medical School and a a practicing physician at
the Massachusetts General Hospital Division of Pulmonary and Critical Care
Medicine.
Dr. Farhat's research focuses on the development and application of methods for associating genotype and phenotype in infectious disease pathogens, with a strong emphasis on translation to better diagnostics and surveillance in resource-poor settings. Farhat's work has focused on bacterial and viral pathoges and spans the spectrum from computational analysis to field studies. She is PI and Co-Investigator on several large projects funded by NIH including the NIAID and the BD2K initiative.
Maha Farhat holds an MD from the McGill University Faculty of Medicine and a MSc in biostatistics from the Harvard Chan School of Public Health.
Journal article
CONCLUSIONS: PASC precision phenotyping boasts superior precision and prevalence estimation while exhibiting less bias in identifying patients with PASC. The cohort derived from this algorithm will serve as a springboard for delving into the genetic, metabolomic, and clinical intricacies of PASC, surmounting the constraints of prior PASC cohort studies.
Journal article
CONCLUSIONS: The results of this study suggest that a genetic locus at 3q29 is associated with PD. This locus is in the phosphatidylinositol glycan anchor biosynthesis class X and p21 activated kinase 2 genes. Twelve candidate genes were identified whose expression may be regulated by this locus. These findings may help us understand both normal and aberrant pancreatic development and may aid in clinical evaluation and genetic counseling of patients with PD and associated diseases, such as acute...